Online Sharing for Head & Neck Cancer Support
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of IOV-5001 in Adults With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Thermotherapy for Head and Neck Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Taiwanese Green Propolis for Lipid Profiles, Fatigue, and Quality of Life in Oral Cavity Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2